|Bid price||0.00||Open price||0.00|
|Ask price||0.00||Prev close||838.50|
Register now for FREE live Abcam share prices, Abcam stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Abcam Level 2 Data, indepth research tools and investor commentary for Abcam (ABC) and other London Stock Exchange equities.
Register now for FREE Abcam share price charts
|Sector||Pharmaceuticals & Biotechnology||ISIN||GB00B6774699|
|Activites||Abcam plc is a leading provider of protein research tools and services, with a wide range of products and expert technical support, enabling scientists to analyse living cells at the molecular level and improving the understanding of health and disease.||Index||n/a|
|Latest Share Price (p)||0.00||Net Gearing (%)||-0.17|
|Market Capitalisation (£m)||1,683.89||Gross Gearing (%)||20.75|
|Shares in issue (m)||202.82||Debt Ratio||11.84|
|P/E Ratio||44.61||Debt-to-Equity Ratio||0.51|
|Total dividends per share (p)||8.91||Assets / Equity Ratio||1.26|
|Dividend Yield (%)||1.07||Price to book value||6.45|
|Dividend cover (x)||2.18||ROCE (%)||15.33|
|Earning per share (p)||18.61||EPS Growth (%)||-0.43|
|52 week high / low||882.50 / 547.00||DPS Growth (%)||8.53|
|Dec.Date||Type||Director||Pos||No. of Shares|
Panmure Gordon today reaffirms its sell investment rating on Abcam PLC (LON:ABC) and raised its price target to 640p (from 636p). Story provided by StockMarketWire.com
Jonathan Milner, Non Executive Director, sold 1,310,370 shares in the company on the 19th September 2016 at a price of 803.99p. The Director now holds 21,994,934 shares. NOTE: Connected parties - wife & trusts etc. Story provided by StockMarketWire.com Director deals data provided by...
Jonathan Milner, Non Executive Director, sold post-exercise 20,361 shares in the company on the 19th September 2016 at a price of 803.88p. The Director now holds 23,325,665 shares. Story provided by StockMarketWire.com Director deals data provided by www.directorsholdings.com
Register now for FREE Abcam company news
Abcam markets research-grade antibodies to academic and commercial users and is headquartered in Cambridge, UK, with a US office in Cambridge, Massachusetts. Its online catalogue of more than 17,000 products is supported by continually updated technical data created by the Company. *...
Everytime I go from one page to another this stupid site logs me out. Stockwatch is particularly bad. Even when I am already logged in it asks me to log in again, and then takes me not to stockwatch but to the homepage. THIS IS INFURIATING!!! I will never pay for any service offered by this site...
Pickings a bit thin on the ground this week and I must admit that my trawl thru the S&P 500 was a bit half hearted. However, this one looks set for a trip back down after failing to make new highs, breaking suport at $52ish and forming, throughout 2002, what looks suspiciously like a shallow head...
Register now for FREE Abcam share price discussions